Gene · 5015
Papers2,975
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,975
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Global Transcriptional and Epigenetic Reconfiguration during Chemical Reprogramming of Human Retinal Pigment Epithelial Cells into Photoreceptor-like Cells. | Cells | 2022 | 36231108 | PubTator, text mining | PubMed |
| Resetting the epigenome: Methylation dynamics in cancer stem cells. | Front Cell Dev Biol | 2022 | 36225315 | PubTator, text mining | PubMed |
| High-resolution genome topology of human retina uncovers super enhancer-promoter interactions at tissue-specific and multifactorial disease loci. | Nat Commun | 2022 | 36207300 | PubTator, text mining | PubMed |
| Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance. | Front Oncol | 2022 | 36203422 | PubTator, text mining | PubMed |
| Ectopic insert-dependent neuronal expression of GFAP promoter-driven AAV constructs in adult mouse retina. | Front Cell Dev Biol | 2022 | 36200040 | PubTator, text mining | PubMed |
| Modeling Human Cerebellar Development In Vitro in 2D Structure. | J Vis Exp | 2022 | 36190246 | PubTator, text mining | PubMed |
| Induced retinal pigment epithelial cells with anti-epithelial-to-mesenchymal transition ability delay retinal degeneration. | iScience | 2022 | 36185374 | PubTator, text mining | PubMed |
| Pluripotency factors are repurposed to shape the epigenomic landscape of neural crest cells. | Dev Cell | 2022 | 36182685 | PubTator, text mining | PubMed |
| Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. | Acta Neuropathol | 2022 | 36181537 | PubTator, text mining | PubMed |
| TGFβ superfamily signaling regulates the state of human stem cell pluripotency and capacity to create well-structured telencephalic organoids. | Stem Cell Reports | 2022 | 36179695 | PubTator, text mining | PubMed |
| Panning for gold: Purifying mesencephalic dopaminergic progenitors differentiated from human pluripotent stem cells. | Stem Cell Reports | 2022 | 36179693 | PubTator, text mining | PubMed |
| Sevoflurane promotes premature differentiation of dopaminergic neurons in hiPSC-derived midbrain organoids. | Front Cell Dev Biol | 2022 | 36176283 | PubTator, text mining | PubMed |
| Eyes on CHARGE syndrome: Roles of CHD7 in ocular development. | Front Cell Dev Biol | 2022 | 36172288 | PubTator, text mining | PubMed |
Exploring the mutational landscape of genes associated with inherited retinal disease using large genomic datasets: identifying loss of function intolerance and outlying propensities for missense changes. | BMJ Open Ophthalmol | 2022 | 36161854 | PubTator, text mining | PubMed |
| Metabolic determinants of stemness in medulloblastoma. | World J Stem Cells | 2022 | 36157911 | PubTator, text mining | PubMed |
| Early anteroposterior regionalisation of human neural crest is shaped by a pro-mesodermal factor. | Elife | 2022 | 36154671 | PubTator, text mining | PubMed |
| Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease. | Stem Cell Reports | 2022 | 36150382 | PubTator, text mining | PubMed |
| Induced hepatic stem cells are suitable for human hepatocyte production. | iScience | 2022 | 36147945 | PubTator, text mining | PubMed |
| Optimization of Lipid Nanoparticles by Response Surface Methodology to Improve the Ocular Delivery of Diosmin: Characterization and In-Vitro Anti-Inflammatory Assessment. | Pharmaceutics | 2022 | 36145708 | PubTator, text mining | PubMed |
| Unified rhombic lip origins of group 3 and group 4 medulloblastoma. | Nature | 2022 | 36131015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5015/papers?page=29